Cargando…

POSA52 A Year-on-Year Comparison Overall German Healthcare Resource Utilization in COVID Versus Non-COVID Times: A German Claims Data Analysis

Detalles Bibliográficos
Autores principales:	Mevius, A, Müller, S, Wilke, T, Maywald, U
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769610/ http://dx.doi.org/10.1016/j.jval.2021.11.197

Ejemplares similares

EPH144 The Impact of COVID-19 Pandemic on the Detection and Management of Cancer: A German Claims Data Analysis
por: Mevius, A, et al.
Publicado: (2022)

POSA32 Early COVID-19 Pandemic in Germany: Patient Characteristics and Clinical Outcomes
por: Pacis, S, et al.
Publicado: (2022)

P21 Social Distancing and Trends in Influenza Hospitalization during the COVID-19 Outbreak: A Difference-in-Difference Analysis of German Claims Data
por: Pacis, S, et al.
Publicado: (2022)

Real-world treatment of German patients with recurrent and advanced endometrial cancer with a post-platinum treatment: a retrospective claims data analysis
por: Mevius, Antje, et al.
Publicado: (2022)

Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis
por: Kreuter, Michael, et al.
Publicado: (2022)

Identifying the Causes Increasing the Risk of Non-Adherence in Adult Patients with Asthma: An Analysis Combining Patient Survey Data with German Claims Data
por: Müller, Sabrina, et al.
Publicado: (2021)

Liver disease epidemiology and burden in patients with alterations in plasma protein metabolism: German retrospective insurance claims analysis
por: Picker, Nils, et al.
Publicado: (2023)

Evaluating the Economic Burden of Relapses in Neuromyelitis Optica Spectrum Disorder: A Real-World Analysis Using German Claims Data
por: Knapp, Rachel K., et al.
Publicado: (2021)

POSA384 Identification of Complications Associated with COVID-19 Infection from Claims Data
por: Arora, A, et al.
Publicado: (2022)

Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis
por: Buhl, Roland, et al.
Publicado: (2022)

Treatment Patterns and Healthcare Resource Utilization Among Patients with Atopic Dermatitis: A Retrospective Cohort Study Using German Health Claims Data
por: Schild, Marie, et al.
Publicado: (2022)

Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis
por: Borchmann, Peter, et al.
Publicado: (2022)

Poststroke epilepsy incidence, risk factors and treatment: German claims analysis
por: Hardtstock, Fränce, et al.
Publicado: (2021)

Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis
por: Wilke, Thomas, et al.
Publicado: (2020)

Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset
por: Mueller, Sabrina, et al.
Publicado: (2018)

The Health Status and Healthcare Utilization of Ethnic Germans in Russia
por: Arena, Charlotte, et al.
Publicado: (2021)

Medication Adherence and Healthcare Costs in Chronically Ill Patients Using German Claims Data
por: Wendl, Johannes, et al.
Publicado: (2023)

Non-persistence and non-adherence to MTX therapy in patients with rheumatoid arthritis: a retrospective cohort study based on German RA patients
por: Müller, Sabrina, et al.
Publicado: (2017)

Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis
por: Kocaata, Zeki, et al.
Publicado: (2022)

Inadequate Response, Treatment Patterns, Health Care Utilization, and Associated Costs in Patients With Ulcerative Colitis: Retrospective Cohort Study Based on German Claims Data
por: Bokemeyer, Bernd, et al.
Publicado: (2022)

The German healthcare system
por: Döring, Andrea, et al.
Publicado: (2010)

Real-world outcomes associated with switching to anti-TNFs versus other biologics in Crohn’s Disease patients: A retrospective analysis using German claims data
por: Zhuleku, Evi, et al.
Publicado: (2022)

10 years of German Medical Science
por: Reinauer, Hans
Publicado: (2013)

Healthcare costs of congenital cytomegalovirus (cCMV) disease in infants during the first two years of life: a retrospective German claims database analysis
por: Stephan, Anna-Janina, et al.
Publicado: (2023)

Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis
por: Hardtstock, Fränce, et al.
Publicado: (2020)

POSA383 Identification of Risk Factors Associated with COVID-19 Hospitalization
por: Chopra, A, et al.
Publicado: (2022)

POSA2 Clinical Features and Management of COVID 19 in Saudi Arabia
por: Ezzi, A, et al.
Publicado: (2022)

German mammography screening program: program sensitivity between 2010 and 2016 estimated based on German health claims data
por: Heinze, Franziska, et al.
Publicado: (2023)

Donde el polvo se posa /
por: Bespalova, Marina, 1970-
Publicado: (1994)

Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims Data
por: Stephan, Anna-Janina, et al.
Publicado: (2022)

EPH35 Post-COVID Conditions in Hospitalized COVID-19 Patients in Germany
por: Pacis, S, et al.
Publicado: (2022)

A Hundred Years Ago: German Measles
Publicado: (1940)

Healthcare Resource Utilization and Associated Costs in New Users of Empagliflozin versus DPP-4 Inhibitors and GLP-1 Agonists: A Comparative Analysis Based on Retrospective Real-World Data from German Sickness Funds
por: Wilke, Thomas, et al.
Publicado: (2022)

The German Lipoprotein Apheresis Registry (GLAR) – almost 5 years on
por: Schettler, V. J. J., et al.
Publicado: (2017)

Time course of dementia following sepsis in German health claims data
por: Fritze, Thomas, et al.
Publicado: (2020)

POSA312 Exploring Health Related Factors Indicating Susceptibility to COVID19
por: Dasgupta, N
Publicado: (2022)

POSA286 Early Experience with Health Technology Assessments for COVID-19 Treatments
por: Sitavu-Radu, X, et al.
Publicado: (2022)

Evaluating student’s ability to assess treatment claims: validating a German version of the Claim Evaluation Tools
por: Hinneburg, Jana, et al.
Publicado: (2023)

Epidemiology, real-world treatment and mortality of patients with status epilepticus in Germany: insights from a large healthcare database
por: Mevius, Antje, et al.
Publicado: (2023)

Comparative analysis of resource utilization in integrative anthroposophic and all German pediatric inpatient departments
por: Fetz, Katharina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v2rbbk4rf8kc41f0oqie1c4p7j